Exact Mass: 477.0883

Exact Mass Matches: 477.0883

Found 23 metabolites which its exact mass value is equals to given mass value 477.0883, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate

(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylic acid

C22H21Cl2N3O5 (477.0858)


   

ARN-509

4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulphanylidene-5,7-diazaspiro[3.4]octan-5-yl}-2-fluoro-N-methylbenzene-1-carboximidic acid

C21H15F4N5O2S (477.0883)


   

Benoxaprofen glucuronide

6-({2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoyl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20ClNO9 (477.0827)


   
   

Acridine mustard

6-CHLORO-9-[3-N-(2-CHLOROETHYL)ETHYLAMINO]PROPYLAMINO-2-METHOXYACRIDINE DIHYDROCHLORIDE

C21H27Cl4N3O (477.0908)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   

GW843682X

5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide

C22H18F3N3O4S (477.097)


   

ARN-509

Apalutamide

C21H15F4N5O2S (477.0883)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen

   

Sulopenem etzadroxil

Sulopenem etzadroxil

C19H27NO7S3 (477.095)


C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

GlcA(b1-3)GalNAc4S

GlcA(b1-3)GalNAc4S

C14H23NO15S (477.0788)


   

Dermatan sulfate

Dermatan sulfate

C14H23NO15S (477.0788)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents D006401 - Hematologic Agents > D000925 - Anticoagulants

   

Chondroitin 4-sulfate

Chondroitin 4-sulfate

C14H23NO15S (477.0788)


   

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H23NO15S (477.0788)


   

N-(5-methyl-3-isoxazolyl)-2-[[1-[[3-(trifluoromethyl)phenyl]methyl]-3-indolyl]sulfonyl]acetamide

N-(5-methyl-3-isoxazolyl)-2-[[1-[[3-(trifluoromethyl)phenyl]methyl]-3-indolyl]sulfonyl]acetamide

C22H18F3N3O4S (477.097)


   

alpha-D-GlcNAc6S-(1->4)-D-GlcA

alpha-D-GlcNAc6S-(1->4)-D-GlcA

C14H23NO15S (477.0788)


A carbohydrate acid derivative that consists of D-glucuronic acid having a 6-O-sulfo-N-acetyl-alpha-D-glucosaminyl residue attached at position 4. An intermediate glycan in the degradation of heparan sulfate.

   

1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone

1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone

C20H23N5O3S3 (477.0963)


   

2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]-N-(3-sulfamoylphenyl)acetamide

2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]-N-(3-sulfamoylphenyl)acetamide

C20H20FN5O4S2 (477.0941)


   

IdoA(a1-3)GalNAc4S

IdoA(a1-3)GalNAc4S

C14H23NO15S (477.0788)


   

GlcA(b1-3)GalNAc6S

GlcA(b1-3)GalNAc6S

C14H23NO15S (477.0788)


   

IdoA(a1-3)GalNAc6S

IdoA(a1-3)GalNAc6S

C14H23NO15S (477.0788)


   

GalNAc4S(b1-4)GlcA

GalNAc4S(b1-4)GlcA

C14H23NO15S (477.0788)


   

IdoA2S(a1-3)GalNAc

IdoA2S(a1-3)GalNAc

C14H23NO15S (477.0788)


   

GalNAc4S(b1-4)b-GlcA

GalNAc4S(b1-4)b-GlcA

C14H23NO15S (477.0788)


   

(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H23NO15S (477.0788)